TERM ID="NYU_TERM_1" STRING="Randomized phase III" FREQUENCY=1 START=479 END=499 LEMMA="RANDOMIZED PHASE III" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="Temsirolimus" FREQUENCY=1 START=244 END=256 LEMMA="TEMSIROLIMUS" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_3" STRING="clinical anti-tumor activity" FREQUENCY=1 START=329 END=357 LEMMA="CLINICAL ANTI-TUMOR ACTIVITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_4" STRING="clinical benefits" FREQUENCY=1 START=545 END=562 LEMMA="CLINICAL BENEFIT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_5" STRING="clinical trial results" FREQUENCY=1 START=914 END=936 LEMMA="CLINICAL TRIAL RESULT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="clinical trials Activation" FREQUENCY=1 START=65 END=91 LEMMA="CLINICAL TRIALS ACTIVATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="clinical trials Activation of mammalian target" FREQUENCY=1 START=65 END=111 LEMMA="MAMMALIAN TARGET CLINICAL TRIALS ACTIVATION" LEMMA_FREQUENCY=1 HEAD_TERM="clinical trials Activation" HEAD_LEMMA="CLINICAL TRIALS ACTIVATION"
TERM ID="NYU_TERM_8" STRING="clinical trials Activation of mammalian target of rapamycin" FREQUENCY=1 START=65 END=124 LEMMA="RAPAMYCIN MAMMALIAN TARGET CLINICAL TRIALS ACTIVATION" LEMMA_FREQUENCY=1 HEAD_TERM="clinical trials Activation of mammalian target" HEAD_LEMMA="MAMMALIAN TARGET CLINICAL TRIALS ACTIVATION"
TERM ID="NYU_TERM_9" STRING="comprehensive collection" FREQUENCY=1 START=882 END=906 LEMMA="COMPREHENSIVE COLLECTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_10" STRING="comprehensive collection of the clinical trial results" FREQUENCY=1 START=882 END=936 LEMMA="CLINICAL TRIAL RESULT COMPREHENSIVE COLLECTION" LEMMA_FREQUENCY=1 HEAD_TERM="comprehensive collection" HEAD_LEMMA="COMPREHENSIVE COLLECTION"
TERM ID="NYU_TERM_11" STRING="endometrial cancer" FREQUENCY=1 START=794 END=812 LEMMA="ENDOMETRIAL CANCER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="hematologic malignancies" FREQUENCY=1 START=992 END=1016 LEMMA="HEMATOLOGIC MALIGNANCY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="hematologic tumor types" FREQUENCY=1 START=379 END=402 LEMMA="HEMATOLOGIC TUMOR TYPE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="mTOR" FREQUENCY=1 START=126 END=130 LEMMA="MAMMALIAN TARGET OF RAPAMYCIN" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_15" STRING="mTOR inhibitors" FREQUENCY=2 START=227 END=242 LEMMA="MTOR INHIBITOR" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_16" STRING="mTOR inhibitors" FREQUENCY=2 START=1208 END=1223 LEMMA="MTOR INHIBITOR" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_17" STRING="mammalian target" FREQUENCY=1 START=95 END=111 LEMMA="MAMMALIAN TARGET" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_18" STRING="mammalian target of rapamycin" FREQUENCY=1 START=95 END=124 LEMMA="MAMMALIAN TARGET OF RAPAMYCIN" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_19" STRING="myeloma" FREQUENCY=1 START=850 END=857 LEMMA="MYELOMA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_20" STRING="non-Hodgkin lymphomas" FREQUENCY=1 START=814 END=835 LEMMA="NON-HODGKIN LYMPHOMA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="preclinical" FREQUENCY=1 START=307 END=318 LEMMA="PRECLINICAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="rapamycin" FREQUENCY=2 START=115 END=124 LEMMA="RAPAMYCIN" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_23" STRING="rapamycin" FREQUENCY=2 START=276 END=285 LEMMA="RAPAMYCIN" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_24" STRING="refractory mantle cell lymphoma" FREQUENCY=1 START=660 END=691 LEMMA="REFRACTORY MANTLE CELL LYMPHOMA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="renal cell carcinoma" FREQUENCY=1 START=619 END=639 LEMMA="RENAL CELL CARCINOMA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="single-agent temsirolimus" FREQUENCY=1 START=581 END=606 LEMMA="SINGLE-AGENT TEMSIROLIMUS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_27" STRING="temsirolimus" FREQUENCY=3 START=958 END=970 LEMMA="TEMSIROLIMUS" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_28" STRING="temsirolimus" FREQUENCY=3 START=1098 END=1110 LEMMA="TEMSIROLIMUS" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_29" STRING="temsirolimus" FREQUENCY=3 START=1185 END=1197 LEMMA="TEMSIROLIMUS" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_30" STRING="temsirolimus activity" FREQUENCY=1 START=11 END=32 LEMMA="TEMSIROLIMUS ACTIVITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_31" STRING="trial settings" FREQUENCY=1 START=742 END=756 LEMMA="TRIAL SETTING" LEMMA_FREQUENCY=1
